227 related articles for article (PubMed ID: 23688816)
21. Lymphangioleiomyomatosis suspected to be a gynecologic disease.
Yamashita S; Nakamura K; Shinozaki H; Minegishi T
J Obstet Gynaecol Res; 2011 Mar; 37(3):267-9. PubMed ID: 21314806
[TBL] [Abstract][Full Text] [Related]
22. Mayo clinic experience of lung transplantation in pulmonary lymphangioleiomyomatosis.
Ussavarungsi K; Hu X; Scott JP; Erasmus DB; Mallea JM; Alvarez F; Lee AS; Keller CA; Ryu JH; Burger CD
Respir Med; 2015 Oct; 109(10):1354-9. PubMed ID: 26321137
[TBL] [Abstract][Full Text] [Related]
23. The efficacy of complex decongestive physiotherapy (CDP) and predictive factors of response to CDP in lower limb lymphedema (LLL) after pelvic cancer treatment.
Liao SF; Li SH; Huang HY
Gynecol Oncol; 2012 Jun; 125(3):712-5. PubMed ID: 22426250
[TBL] [Abstract][Full Text] [Related]
24. Lung transplantation for lymphangioleiomyomatosis: role of imaging in the assessment of complications related to the underlying disease.
Collins J; Müller NL; Kazerooni EA; McAdams HP; Leung AN; Love RB
Radiology; 1999 Feb; 210(2):325-32. PubMed ID: 10207410
[TBL] [Abstract][Full Text] [Related]
25. Lymphangioleiomyomatosis.
Johnson SR
Eur Respir J; 2006 May; 27(5):1056-65. PubMed ID: 16707400
[TBL] [Abstract][Full Text] [Related]
26. Study of edema reduction patterns during the treatment phase of complex decongestive physiotherapy for extremity lymphedema.
Yamamoto T; Todo Y; Kaneuchi M; Handa Y; Watanabe K; Yamamoto R
Lymphology; 2008 Jun; 41(2):80-6. PubMed ID: 18720915
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic and Treatment Monitoring Potential of Serum Vascular Endothelial Growth Factor-D in Lymphangioleiomyomatosis.
Mou Y; Ye L; Wang J; Yee MS; Song YL; Zhu L; Jin ML
Lymphology; 2016 Sep; 49(3):140-9. PubMed ID: 29906075
[TBL] [Abstract][Full Text] [Related]
28. Lymphangioleiomyomatosis: A review.
Hohman DW; Noghrehkar D; Ratnayake S
Eur J Intern Med; 2008 Jul; 19(5):319-24. PubMed ID: 18549932
[TBL] [Abstract][Full Text] [Related]
29. Long-term management of breast cancer-related lymphedema after intensive decongestive physiotherapy.
Vignes S; Porcher R; Arrault M; Dupuy A
Breast Cancer Res Treat; 2007 Mar; 101(3):285-90. PubMed ID: 16826318
[TBL] [Abstract][Full Text] [Related]
30. SUCCESSFUL TREATMENT OF PULMONARY AND LYMPHATIC MANIFESTATIONS OF LYMPHANGIOLEIOMYOMATOSIS WITH SIROLIMUS.
Hecimovic A; Jakopovic M; Pavlisa G; Jankovic M; Vukic-Dugac A; Redzepi G; Brcic L; Samarzija M; Gupta N
Lymphology; 2015 Jun; 48(2):97-102. PubMed ID: 26714374
[TBL] [Abstract][Full Text] [Related]
31. [Sporadic lymphangioleiomyomatosis and pulmonary hypertension. Clinical and pathologic study in patients undergoing lung transplantation].
Ansótegui Barrera E; Mancheño Franch N; Peñalver Cuesta JC; Vera-Sempere F; Padilla Alarcón J
Med Clin (Barc); 2012 May; 138(13):570-3. PubMed ID: 22440137
[TBL] [Abstract][Full Text] [Related]
32. Lymphangioleiomyomatosis: CT of diurnal variation of lymphangioleiomyomas.
Avila NA; Bechtle J; Dwyer AJ; Ferrans VJ; Moss J
Radiology; 2001 Nov; 221(2):415-21. PubMed ID: 11687685
[TBL] [Abstract][Full Text] [Related]
33. A Case of Lymphangioleiomyomatosis (LAM) of the Lung in a Patient with a History of Breast Cancer.
Koc-Günel S; Tekeli N; Smaczny C; Vogl T; Rohde G
Am J Case Rep; 2019 Mar; 20():390-393. PubMed ID: 30905927
[TBL] [Abstract][Full Text] [Related]
34. A rare clinical manifestation of lymphedema praecox affecting the upper extremity.
Malá J; Malý R; Vršanská V; Doležal J; Popper E; Ettler K
Vasa; 2013 May; 42(3):218-22. PubMed ID: 23644374
[No Abstract] [Full Text] [Related]
35. [Lymphangioleiomyomatosis (LAM)--an uncommon cause of bilateral spontaneous pneumothorax].
Grigorescu C; Bosânceanu M; Boişteanu D; Aldea A; Chiseliţă I; Cozma LG
Rev Med Chir Soc Med Nat Iasi; 2007; 111(1):125-8. PubMed ID: 17595857
[TBL] [Abstract][Full Text] [Related]
36. Sirolimus Therapy for Patients With Lymphangioleiomyomatosis Leads to Loss of Chylous Ascites and Circulating LAM Cells.
Harari S; Elia D; Torre O; Bulgheroni E; Provasi E; Moss J
Chest; 2016 Aug; 150(2):e29-32. PubMed ID: 27502989
[TBL] [Abstract][Full Text] [Related]
37. Decongestive lymphatic therapy for patients with breast carcinoma-associated lymphedema. A randomized, prospective study of a role for adjunctive intermittent pneumatic compression.
Szuba A; Achalu R; Rockson SG
Cancer; 2002 Dec; 95(11):2260-7. PubMed ID: 12436430
[TBL] [Abstract][Full Text] [Related]
38. Serum vascular endothelial growth factor-D levels in patients with lymphangioleiomyomatosis reflect lymphatic involvement.
Glasgow CG; Avila NA; Lin JP; Stylianou MP; Moss J
Chest; 2009 May; 135(5):1293-1300. PubMed ID: 19420197
[TBL] [Abstract][Full Text] [Related]
39. Meningiomas in lymphangioleiomyomatosis.
Moss J; DeCastro R; Patronas NJ; Taveira-DaSilva A
JAMA; 2001 Oct; 286(15):1879-81. PubMed ID: 11597290
[TBL] [Abstract][Full Text] [Related]
40. Menstrual cycle variation of retroperitoneal lymphangioleiomyomas in lymphangioleiomyomatosis.
Sandrini A; Silverstone E; Yates DH
Intern Med J; 2011 Dec; 41(12):832-5. PubMed ID: 22151950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
